QPS implements DEBRA LIMS for Radiolabeled Metabolism Studies - August, 2013

(Newark, DE; August 20, 2013) – QPS, a leading preclinical and clinical CRO, announced today that it has fully validated LabLogic Debra version 6.0.6 for use in radiolabeled metabolism studies. An earlier version was implemented in 2010 to support discovery stage radiolabel ADME studies. The implementation of Debra LIMS coupled with the recent addition of a high resolution mass spectrometer (HRMS) ensures rapid integration of radioactivity data from mass balance excretion and/or quantitative whole-body autoradiography (QWBA) studies with metabolite identification and radio-quantitation to shorten timelines in support of preclinical and human mass balance studies.

Huw Loaring, PhD, LabLogic’s Systems Director said “There are currently seven sites who have upgraded to Debra 6 and we are very pleased to have worked closely with QPS developing bespoke test scripts for them. QPS is our first contract laboratory to be using this latest release in a fully validated environment.”

Zamas Lam, Ph.D., Senior Vice President & Global Head of Pre-Clinical Development, states “Implementation of a fully validated LIMS will further guarantee data quality, improve efficiency, and provide additional flexibility. As a world class DMPK service provider this type of continuous improvement initiative is paramount to providing unparalleled services to our world-wide customers.”

About QPS

QPS is a GLP/GCP-compliant CRO that supports discovery and preclinical and clinical drug development. We provide quality services in Neuropharmacology, Drug Metabolism and Pharmacokinetics, Toxicology, Bioanalysis, Translational Medicine, and Early & Late Phase Clinical Research to clients worldwide. Our 30+ regional laboratories, clinical facilities and offices are located in North America, Europe, Asia, and the Middle East. For more information, visit


Zamas Lam, Ph.D.
Senior Vice President and Global Head of Pre-Clinical Development
3 Innovation Way, Delaware Technology Park, Newark DE 19711
+1 (302) 369-5117

20 years in pharma R&D navigation